{"cluster": 69, "subcluster": 59, "abstract_summ": " The ensuing COVID-19 pandemic poses unprecedented challenges to the routine delivery of oncological and supportive care to patients with breast cancer . Considerations include the infective risk of patients who are inherently immunosuppressed from their malignancy and therapies ."}